Genetic Technologies Limited (GENE)

Etorro trading 970x250
Genetic Technologies Limited (GENE) Logo

About Genetic Technologies Limited

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women’s health in Australia and the United States. The company’s lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company engages in the development of various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer name. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was founded in 1989 and is headquartered in Fitzroy, Australia. Address: 60-66 Hanover Street, Fitzroy, VIC, Australia, 3065

Genetic Technologies Limited News and around…

Latest news about Genetic Technologies Limited (GENE) common stock and company :

12 Health Care Stocks Moving In Monday's Pre-Market Session
04 Oct, 2021 FinancialContent

Gainers OpGen (NASDAQ:OPGN) shares moved upwards by 30.07% to $3.59 during Monday's pre-market session. The market ...

GENE Delivers Material 12-Fold Increase in Revenue in the Quarter Ended September 2021
04 Oct, 2021 Yahoo! Finance

Commercialisation plans gather momentumMELBOURNE, Australia, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease, announces a 12-fold increase in revenue generated during the September 2021 quarter to A$850k1. Highlights: Delivering a material 12-fold increase in customer receipts to A$850k, versus June 2021 quarterRevenue primarily derived from license and resa

Genetic Technologies Limited Interview to Air on Bloomberg TV (U.S.) on the RedChip Money Report®
30 Sep, 2021 FinancialContent
GENE Embarks on Breakthrough African American Collaboration for Breast Cancer as Part of Its Commitment to Ethnic Diversity
28 Sep, 2021 FinancialContent

Study to focus on women of African American descent for expanded polygenic risk test

BelHealth Completes Asset Sale of General Genetics Corp.
09 Sep, 2021 Yahoo! Finance

September 9, 2021–BelHealth Investment Partners, LLC ("BelHealth") is pleased to announce that it has completed the sale of assets of the international division of General Genetics Corporation (GGC), a provider of relationship and clinical genetic testing services, to Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a diversified molecular diagnostics company ("GTG"). The transaction was structured in a combination of cash and stock of GTG.

Genetic Technologies Reports FY21 Results as it Turns the Corner on its Commercialization Strategy
31 Aug, 2021 FinancialContent

Company to present at H.C. Wainwright 23rd Annual Global Investment Conference taking place virtually September 13-15, 2021

Genetic Technologies Enters Multi-Billion-Dollar Consumer Genomics Market
16 Aug, 2021 FinancialContent

EasyDNA Acquisition Accelerates Global Expansion Plans

Bullish Sentiment Pushing Cannabis Stocks Up, Check Out Top Movers For July 28, 2021
28 Jul, 2021 FinancialContent

GAINERS: Tilray(NASDAQ: TLRY) shares closed up 25.77% at $16.01 MedMen Enterprises(OTC: MMNFF) shares closed up ...

Sundial Growers, MedMen, World Acceptance Among Top Cannabis Stock Movers On July 26, 2021
26 Jul, 2021 FinancialContent

GAINERS: Khiron Life Sciences(OTC: KHRNF) shares closed up 10.23% at $0.25 Nine Energy Service(NYSE: NINE) shares ...

Genetic Technologies Rapidly Accelerating Commercialization Plans
26 Jul, 2021 FinancialContent
Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish
20 Jul, 2021 FinancialContent

A differentiated approach to gene editing has ushered a bullish sentiment from BofA Securitiesand Morgan Stanley on Graphite Bio, ...

Genetic Technologies Acquires EasyDNA To Expand Into Wellness Testing
19 Jul, 2021 FinancialContent

Genetic Technologies Limited(NASDAQ: GENE)has agreed to acquire EasyDNA'sbrand and distribution rights from ...

Genetic Technologies Strengthens Global Leadership in Genomics with Acquisition of EasyDNA
19 Jul, 2021 FinancialContent

A global platform to market the Company’s portfolio across 40 countries

World Acceptance, Cresco Labs And TerrAscend Among Top Cannabis Stock Movers On July 15, 2021
15 Jul, 2021 FinancialContent

GAINERS: Benchmark Botanics(OTC: BHHKF) shares closed up 247.25% at $0.14 Rhinomed(OTC: RHNMF) shares closed up ...

Genetic Technologies Continues to Break New Ground as it Advances Development of its Predictive Risk Test for Multiple Cancers & Morbidities
09 Jul, 2021 FinancialContent
12 Health Care Stocks Moving In Thursday's Pre-Market Session
08 Jul, 2021 FinancialContent

Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock moved upwards by 43.27% to $2.45 during Thursday's pre-market ...

Sundial Growers, Cresco Labs, RIV Capital Among Top Cannabis Stock Movers On July 7, 2021
07 Jul, 2021 FinancialContent

GAINERS: BioHarvest Sciences(OTC: CNVCF) shares closed up 28.3% at $0.34 Eastside Distilling(NASDAQ: EAST) shares ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
14 Jun, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, traders! We're starting off another busy week of trading right with a look at the biggest pre-market stock movers for Monday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

22 Stocks Moving in Monday's Pre-Market Session
14 Jun, 2021 FinancialContent

Gainers MediaCo Holding Inc. (NASDAQ: MDIA) rose 73.4% to $6.66 in pre-market trading. MediaCo, last week, named Rahsan-Rahsan ...

Cannabis Stock Gainers And Losers From June 11, 2021
11 Jun, 2021 FinancialContent

GAINERS: CURE Pharmaceutical Hldg(OTC: CURR) shares closed up 12.33% at $0.82 Psychemedics(NASDAQ: PMD) shares ...

US Patent Office Grants Foundational Pharmacogenomic Patent
11 Jun, 2021 FinancialContent
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
10 Jun, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, investors! We're at it again with another look at the biggest pre-market stock movers for Thursday morning. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

62 Biggest Movers From Yesterday
10 Jun, 2021 FinancialContent

Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article ...

Wednesday Sector Leaders: Shipping, Diagnostics
09 Jun, 2021 FinancialContent

In trading on Wednesday, shipping shares were relative leaders, up on the day by about 1.9%. Leading the group were shares of Global Ship Lease, up about 11.6% and shares of Navios Maritime Holdings up about 7.3% on the day.

Infinity BiologiX, Genetic Technologies and Vault Heath launch new test to assess severity of COVID-19 in individuals
09 Jun, 2021 FinancialContent

Today, Infinity BiologiX (IBX) announces the launch of a new test meant to assess the severity of COVID-19 in individuals. The COVID-19 Risk Test is designed to predict disease severity in people ages 18 and older, using genetic and clinical information to provide a risk score - individuals can then use that score to understand their personal risk of contracting a serious case of COVID-19 and make more informed decisions.

First Week of July 16th Options Trading For Genetic Technologies (GENE)
02 Jun, 2021 FinancialContent

Investors in Genetic Technologies Ltd. (GENE) saw new options begin trading this week, for the July 16th expiration..

Cannabis Stock Gainers And Losers From June 1, 2021
01 Jun, 2021 FinancialContent

GAINERS: Hollister Biosciences(OTC: HSTRF)shares closed up 34.09% at $0.30 The Flowr(OTC: FLWPF)shares ...

Tuesday Sector Laggards: Diagnostics, Biotechnology Stocks
01 Jun, 2021 FinancialContent

In trading on Tuesday, diagnostics shares were relative laggards, down on the day by about 0.9%. Helping drag down the group were shares of Genetic Technologies, off about 10% and shares of Viemed Healthcare off about 6.3% on the day.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
01 Jun, 2021 FinancialContent

Gainers Paratek Pharmaceuticals (NASDAQ:PRTK) stock increased by 12.65% to $9.26 during Tuesday's pre-market ...

Genetic Technologies’ COVID-19 Risk Test Now Available in US through Partnership with Infinity BiologiX
01 Jun, 2021 FinancialContent

Test improves COVID-19 prevention and management capabilities for employers, governments, and public health decision makers

Genetic Technologies Limited (GENE) is a NASDAQ Common Stock listed in , ,

970x250